Appendix 4E and 2017 Annual Report
Filed with ASX · · 58 pages · English
Story so far
Earlier from Micro-X
- R&D tax rebate
- Carestream receives FDA 510(k) Approval for Nano
- Successful completion of $4.8M entitlement offer
- Micro-X Entitlement Offer now fully underwritten
- Entitlement Offer
Later from Micro-X
- Nano Commercialisation - First From Production Acceptance
- Appendix 4D and Half Year Financial Report
- Nano commercialisation update
- Successful completion of $5.0M capital raising
- R&D contract signed with UK ministry of Defence
Follow Micro-X into a list and get an email when it puts out news.
Follow Micro-X